» Articles » PMID: 30702452

Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism

Overview
Journal J Patient Saf
Specialty Health Services
Date 2019 Feb 1
PMID 30702452
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of the study was to assess the feasibility, satisfaction, and effectiveness of a care transition intervention with pharmacist home visit and subsequent anticoagulation expert consultation for patients with new episode of venous thromboembolism within a not-for-profit health care network.

Methods: We randomized patients to the intervention or control. During the home visit, a clinical pharmacist assessed medication management proficiency, asked open-ended questions to discuss knowledge gaps, and distributed illustrated medication instructions. Subsequent consultation with anticoagulation expert further filled knowledge gaps. At 30 days, we assessed satisfaction with the intervention and also measured the quality of care transition, knowledge of anticoagulation and venous thromboembolism, and anticoagulant beliefs (level of agreement that anticoagulant is beneficial, is worrisome, and is confusing/difficult to take).

Results: The mean ± SD time required to conduct home visits was 52.4 ± 20.5 minutes and most patients agreed that the intervention was helpful. In general, patients reported a high-quality care transition including having been advised of safety issues related to medications. Despite that, the mean percentage of knowledge items answered correctly among patients was low (51.5 versus 50.7 for intervention and controls, respectively). We did not find any significant difference between intervention and control patients for care transition quality, knowledge, or anticoagulant beliefs.

Conclusions: We executed a multicomponent intervention that was feasible and rated highly. Nevertheless, the intervention did not improve care transition quality, knowledge, or beliefs. Future research should examine whether alternate strategies potentially including some but not all components of our intervention would be more impactful.

Citing Articles

Identifying and mapping measures of medication safety during transfer of care in a digital era: a scoping literature review.

Leon C, Hogan H, Jani Y BMJ Qual Saf. 2023; 33(3):173-186.

PMID: 37923372 PMC: 10894843. DOI: 10.1136/bmjqs-2022-015859.


Medication Supports at Transitions Between Hospital and Other Care Settings: A Rapid Scoping Review.

Varghese S, Hahn-Goldberg S, Deng Z, Bradley-Ridout G, Guilcher S, Jeffs L Patient Prefer Adherence. 2022; 16:515-560.

PMID: 35241910 PMC: 8887864. DOI: 10.2147/PPA.S348152.


Reducing Hospitalizations and Emergency Department Visits in Patients With Venous Thromboembolism Using a Multicomponent Care Transition Intervention.

Kapoor A, Bloomstone S, Javed S, Silva M, Lynch A, Yogaratnam D Inquiry. 2020; 57:46958019900080.

PMID: 31965873 PMC: 6977209. DOI: 10.1177/0046958019900080.

References
1.
White R . The epidemiology of venous thromboembolism. Circulation. 2003; 107(23 Suppl 1):I4-8. DOI: 10.1161/01.CIR.0000078468.11849.66. View

2.
Pernod G, Labarere J, Yver J, Satger B, Allenet B, Berremili T . EDUC'AVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study. J Gen Intern Med. 2008; 23(9):1441-6. PMC: 2518037. DOI: 10.1007/s11606-008-0690-1. View

3.
Katz M, Kripalani S, Weiss B . Use of pictorial aids in medication instructions: a review of the literature. Am J Health Syst Pharm. 2006; 63(23):2391-7. DOI: 10.2146/ajhp060162. View

4.
Kripalani S, Roumie C, Dalal A, Cawthon C, Businger A, Eden S . Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012; 157(1):1-10. PMC: 3575734. DOI: 10.7326/0003-4819-157-1-201207030-00003. View

5.
Geurts M, Talsma J, Brouwers J, de Gier J . Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol. 2012; 74(1):16-33. PMC: 3394125. DOI: 10.1111/j.1365-2125.2012.04178.x. View